PDS Biotechnology annual ebitda
2018
2019
2020
PDS Biotechnology EBITDA Growth & History (PDSB)
PDS Biotechnology's calculated EBITDA was −$14.9M for fiscal 2020.
View full PDS Biotechnology company overviewPDS Biotechnology annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2020 | 2020-12-31 | −$14.9M | $6.0M | — |
| 2019 | 2019-12-31 | −$20.9M | −$17.4M | — |
| 2018 | 2018-12-31 | −$3.6M | — | — |
PDS Biotechnology quarterly ebitda
Q1.19
Q1.20
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q1 2020 | 2020-03-31 | −$4.0M | — | — |
| Q1 2019 | 2019-03-31 | −$4.9M | — | — |
PDS Biotechnology ebitda trends
Across the available reported history, PDS Biotechnology's ebitda increased from −$20.9M to −$14.9M, a change of $6.0M. The latest reported quarter, Q1 2020, shows −$4.0M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PDS Biotechnology filings at SEC.gov ↗